Status:
COMPLETED
Invasive Pulmonary Aspergillosis Complicating Influenza Infection
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Influenza With Pneumonia
Aspergillosis Invasive
Eligibility:
All Genders
18+ years
Brief Summary
Study the incidence and outcome of invasive pulmonary aspergillosis (IPA) in ICU patients with severe influenza and in influenza-negative control patients with severe community-acquired pneumonia
Detailed Description
This prospective multicentre case-control registration study in Dutch and Belgian ICUs will assess the difference in incidence and outcome of invasive pulmonary aspergillosis (IPA) in ICU patients wit...
Eligibility Criteria
Inclusion
- patient older than 18 years,admitted to ICU with respiratory distress with microbiologically confirmed diagnosis of influenza (for inclusion in the influenza group)
- patients older than 18 years, admitted to ICU for respiratory distress due to community-acquired pneumonia , with a microbiologically confirmed absence of influenza (for inclusion in the control group)
Exclusion
- age \< 18 year
- no informed consent
Key Trial Info
Start Date :
January 20 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
298 Patients enrolled
Trial Details
Trial ID
NCT03391492
Start Date
January 20 2018
End Date
June 30 2021
Last Update
July 30 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
AZ sint Jan
Bruges, Belgium, 8000
2
Jessa AH
Hasselt, Belgium, 3500